Prosecution Insights
Last updated: April 19, 2026
Application No. 17/727,670

HEARING DEVICE COMPRISING A SHIELDING COMPONENT

Non-Final OA §103
Filed
Apr 22, 2022
Examiner
FALEY, KATHERINE A
Art Unit
2693
Tech Center
2600 — Communications
Assignee
Gn Hearing A/S
OA Round
9 (Non-Final)
66%
Grant Probability
Favorable
9-10
OA Rounds
2y 6m
To Grant
99%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allow Rate
289 granted / 439 resolved
+3.8% vs TC avg
Strong +45% interview lift
Without
With
+44.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
19 currently pending
Career history
458
Total Applications
across all art units

Statute-Specific Performance

§101
2.4%
-37.6% vs TC avg
§103
44.7%
+4.7% vs TC avg
§102
16.9%
-23.1% vs TC avg
§112
28.4%
-11.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 439 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION This is in response to Applicants Request for Continued Examination filed 11/5/25 which has been entered. Claims 5, 14, 26, 33, and 36 have been amended. No claims have been cancelled. No claims have been added. Claims 3-7, 10-11, 13-14, 16, 18, 22-26, and 30-38 are still pending in this application, with Claims 5 and 14 being independent. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 5, 3-4, 7, 10, 13-14, 16, 18, 21-26, and 30-32 is/are rejected under 35 U.S.C. 103 as being unpatentable over Pedersen US Publication No. 20180109890 in view of Lin US Publication No. 20050117352. Referring to claim 5, Pedersen teaches a hearing device configured to be worn at or in an ear of a user (para 0001: “The present disclosure relates to protective measures for components of hearing devices. More particularly, the disclosure relates to hearing devices, such as hearing aids”; Figs. 1, 10: hearing aid 100/1000), the hearing device comprising: a substrate (para 0039: “the at least one electrical component 110 may be arranged on a substrate (e.g. PCB) and the substrate may form a second cavity enclosure component of the cavity enclosure structure 120 fixed to a first cavity enclosure component of the cavity enclosure structure 120”; Fig. 10: PCB 206); one or more electronic components mounted on the substrate (Fig. 10: electrical components 110 on PCB 206; para 0039: “the at least one electrical component 110 may be arranged on a substrate (e.g. PCB) and the substrate may form a second cavity enclosure component of the cavity enclosure structure 120”); and a shielding component configured to cover at least a first electronic component of the one or more electronic components on the substrate (Figs. 1, 10: cavity enclosure structure 120 (composed of housing component 208 in Fig. 10) covers electrical components 110); wherein a space between the shielding component and the substrate is at least partly filled with an encapsulation material configured to encapsulate at least the first electronic component (Fig. 1: filling material 130 fills cavity 112 around electrical component 110); a filling hole at the shielding component (Figs. 1, 10: cavity enclosure structure 120 (composed of housing component 208 in Fig. 10), the filling hole configured to deliver the encapsulation material to at least a part of the space (Fig. 9: injection hole 122; para 0024: “filling material 130 can be injected into the cavity 112 through the injection hole 122”), the substrate of the hearing device (para 0039: “the at least one electrical component 110 may be arranged on a substrate (e.g. PCB) and the substrate may form a second cavity enclosure component of the cavity enclosure structure 120 fixed to a first cavity enclosure component of the cavity enclosure structure 120”; Fig. 10: PCB 206 of hearing aid 1000) and a first air escape hole at the shielding component (Figs. 9, 10: opening 124 in part of cavity enclosure structure 120 (composed of housing component 208 in Figs. 9, 10); para 0028: “such first-type opening may also be used for ventilation alone and/or have a double function and used for both ventilation and visual inspection purposes”) wherein the shielding component has a part disposed directly over the major surface of the substrate (Fig. 10: housing component 208 disposed over major surface of PCB 206). Though Pedersen teaches that “the injection hole 122 and/or the opening 124 may be arranged in a cavity enclosure component being part of the housing structure of the hearing aid”, Pedersen does not explicitly show all possible locations of the holes in relation to filling, but Lin et al. teaches the filling hole is directly above a major surface of the substrate, and wherein the filling hole has a hole axis (1) extending through a middle of the filling hole in a direction that is perpendicular to a plane defined by a perimeter of the filling hole, and (2) intersecting the major surface of the substrate, and wherein the filling hole is a distance away from the major surface of the substrate (Fig. 9: rightmost hole 133 directly above and spaced away from major surface of film 16 and axis of injection hole 133 intersects film 16; para 0065: “The holes 133…as means of bond injection”); a first air escape hole (Fig. 9: uppermost hole 133; para 0065: “The holes 133…as means of …ventilation”) wherein the shielding component has a part disposed directly over the major surface of the substrate (Fig. 9: support 13A has top directly over major surface of film 16), wherein both the filling hole and the first air escape hole are at the part of the shielding component (Fig. 9: holes 133 all at top of support 13A), and wherein the filling hole is closer to a center of the shielding component than to two opposite ends of the shielding component (Fig. 9: rightmost hole 133 closer to direct center point of support 13A than to opposite end corners of leftmost and uppermost holes 133 of support 13A). A person having ordinary skill in the art before the effective filing date of the claimed invention would have had good reason to pursue the known finite options of placing the injection and inspection holes in the walls of the cavity enclosure component, therefore it would have been obvious to try placing the holes on a wall opposite to the substrate and injecting material downward, as taught in Lin, as opposed to putting the injection hole on a side wall or in the substrate, as more clearly shown in Pedersen, because this placement and orientation allows for easy injection of material into the space within. Referring to claim 3, Pedersen teaches the shielding component comprises an internal face facing towards the substrate, and wherein the shielding component comprises an external face facing towards a surrounding (Figs. 1, 10: cavity enclosure structure 120/housing component 208 comprises internal face facing electrical components 110 and external face facing a surrounding). Referring to claim 4, Pedersen teaches the shielding component comprises a reservoir, and wherein the reservoir is at least partly defined by a portion of the external face of the shielding component (Figs. 9, 10: overflow cavities 203 and injection hole 122 defined by external faces of housing component 208). Referring to claim 7, Pedersen teaches the shielding component is made from a solid metal plate (para 0040). Referring to claim 10, Pedersen teaches the shielding component has a first height above the substrate, wherein the first height of the shielding component corresponds with a height of the first electronic component (Fig. 1: height of 120 corresponds to height of electronic component 110). Referring to claim 13, Pedersen teaches the part of the shielding component extends in a direction that is parallel to the major plane of the substrate (Fig. 10: wall of 208 opposite to PCB 206 extends in a direction parallel to major plane of PCB 206). Lin also shows injection hole 133 in top of support 13A, which is parallel to film 16. Motivation to combine is the same as in claim 5. Referring to claim 14, Pedersen teaches a hearing device configured to be worn at or in an ear of a user (para 0001: “The present disclosure relates to protective measures for components of hearing devices. More particularly, the disclosure relates to hearing devices, such as hearing aids”; Figs. 1, 10: hearing aid 100/1000), the hearing device comprising: a substrate (para 0039: “the at least one electrical component 110 may be arranged on a substrate (e.g. PCB) and the substrate may form a second cavity enclosure component of the cavity enclosure structure 120 fixed to a first cavity enclosure component of the cavity enclosure structure 120”; Fig. 10: PCB 206); one or more electronic components mounted on the substrate (Fig. 10: electrical components 110 on PCB 206; para 0039: “the at least one electrical component 110 may be arranged on a substrate (e.g. PCB) and the substrate may form a second cavity enclosure component of the cavity enclosure structure 120”); and a shielding component configured to cover at least a first electronic component of the one or more electronic components on the substrate (Figs. 1, 10: cavity enclosure structure 120 (composed of housing component 208 in Fig. 10) covers electrical components 110); wherein a space between the shielding component and the substrate is at least partly filled with an encapsulation material configured to encapsulate at least the first electronic component (Fig. 1: filling material 130 fills cavity 112 around electrical component 110); wherein the shielding component comprises a reservoir configured to receive an excess encapsulation material that is outside the space between the shielding component and the substrate (Fig. 10: overflow cavity 203 in housing component 208, further cavities exist by holes 122, 124; para 0067: “In case of too much filling material is injected the overflow cavity will be utilized”; para 0024: “the filling material 130 extends from the injection hole 122 to the opening 124 through the cavity and fills at least partly the injection hole 122 and optionally also the opening 124.”;); wherein the shielding component comprises a first air escape hole (Figs. 9, 10: opening 124 in part of cavity enclosure structure 120 (composed of housing component 208 in Figs. 9, 10); para 0028: “such first-type opening may also be used for ventilation alone and/or have a double function and used for both ventilation and visual inspection purposes”) and a filling hole, the filling hole configured to receive the encapsulation material to at least partially fill the space between the shielding component and the substrate (Fig. 9: injection hole 122; para 0024: “filling material 130 can be injected into the cavity 112 through the injection hole 122”); and the shielding component comprises a part disposed over a major surface of the substrate (Fig. 10: housing component 208 disposed over major surface of PCB 206), the substrate of the hearing device (para 0039: “the at least one electrical component 110 may be arranged on a substrate (e.g. PCB) and the substrate may form a second cavity enclosure component of the cavity enclosure structure 120 fixed to a first cavity enclosure component of the cavity enclosure structure 120”; Fig. 10: PCB 206 of hearing aid 1000). Though Pedersen teaches that “the injection hole 122 and/or the opening 124 may be arranged in a cavity enclosure component being part of the housing structure of the hearing aid”, Pedersen does not explicitly show all possible locations of the holes in relation to filling, but Lin teaches the first air escape hole and the filling hole (para 0065: “The holes 133…as means of bond injection or ventilation”) are both directly above the major surface of the substrate, and wherein the filling hole is a distance away from the major surface of the substrate (Fig. 9: holes 133 directly above and spaced from the major surface of film 16) and wherein the filling hole at the part of the shielding component is closer to a center of the shielding component than to two opposite ends of the shielding component (Fig. 9: rightmost hole 133 closer to direct center point of support 13A than to opposite end corners of leftmost and uppermost holes 133 of support 13A). A person having ordinary skill in the art before the effective filing date of the claimed invention would have had good reason to pursue the known finite options of placing the injection and air holes in the walls of the cavity enclosure component, therefore it would have been obvious to try placing the holes on a wall above the substrate and injecting material downward, as taught in Lin, as opposed to putting the holes on a side wall or in the substrate, as more clearly shown in Pedersen, because this placement and orientation allows for easy injection of material into the space within. Referring to claim 16, Pedersen teaches the shielding component comprises a reservoir configured to receive an excess encapsulation material that is outside the space between the shielding component and the substrate (Fig. 9: injection hole 122 in housing component 208; para 0024: “the filling material 130…fills at least partly the injection hole 122”;) and Lin teaches the part of the shielding component comprises a top part, and wherein the reservoir is a recess at the top part of the shielding component (Fig. 9: rightmost hole 133 is recess at top part of support 13A). Motivation to combine is the same as in claim 5. Referring to claim 18, Lin teaches the reservoir is a recess at a top part of the shielding component (Fig. 9: rightmost hole 133 is recess at top part of support 13A). Motivation to combine is the same as in claim 14. Referring to claim 22, Pedersen teaches the filling hole is at the reservoir, and the first air escape hole is away from the filling hole (Fig. 9: injection hole 122 away from opening 124; Fig. 5: also shows injection hole 244 and openings 246, 248 away from one another; para 0026: “the injection hole 122 and the (first) opening 124 may be located far away from each other to enable a substantially complete filling of the cavity”). Lin also shows holes 133 away from each other. Motivation to combine is the same as in claim 14. Referring to claim 23, Pedersen teaches the shielding component has a bottom side and a top side opposite from the bottom side, wherein the substrate is located closer to the bottom side of the shielding component than to the top side of the shielding component, and wherein the first air escape hole and the filling hole are both at the top side of the shielding component (Fig. 5: both injection hole 244 and openings 246, 248 at side of chassis opposite to side near PCB 240). Lin also shows holes 133 in top of support 13A, which is opposite to film 16. Motivation to combine is the same as in claim 5. Referring to claim 24, Pedersen teaches the shielding component has a bottom side and a top side opposite from the bottom side, wherein the substrate is located closer to the bottom side of the shielding component than to the top side of the shielding component, and wherein the first air escape hole and the filling hole are both at the top side of the shielding component (Fig. 5: both injection hole 244 and openings 246, 248 at side of chassis opposite to side near PCB 240). Lin also shows holes 133 in top of support 13A, which is opposite to film 16. Motivation to combine is the same as in claim 14. Referring to claim 25, Pedersen teaches the filling hole is at a wall of the shielding component (Fig. 9: injection hole 122 in wall of housing component 208). Referring to claim 26, Lin teaches the part of the shielding component is at a top side of the shielding component, wherein both the filling hole and the first air escape hole are at a same side of the shielding component (Fig. 9: holes 133 at the top side of support 13A). Motivation to combine is the same as in claim 5. Referring to claim 30, Lin teaches the filling hole has a hole axis (1) extending through a middle of the filling hole in a direction that is perpendicular to a plane defined by a perimeter of the filling hole, and (2) intersecting the major surface of the substrate (Fig. 9: axis of rightmost hole 133 intersects film 16). Motivation to combine is the same as in claim 14. Referring to claim 31, Pedersen teaches the shielding component comprises a reservoir configured to receive an excess encapsulation material that is outside the space between the shielding component and the substrate (Fig. 9: injection hole 122 in housing component 208; para 0024: “the filling material 130…fills at least partly the injection hole 122”;), the reservoir comprising the filling hole (Fig. 9: injection hole 122 part of hearing aid 900). Referring to claim 32, Pedersen teaches the shielding component comprising the first air escape hole (Figs. 9, 10: opening 124 in part of cavity enclosure structure 120 (composed of housing component 208 in Figs. 9, 10); para 0028: “such first-type opening may also be used for ventilation alone and/or have a double function and used for both ventilation and visual inspection purposes”) and the filling hole (Fig. 9: injection hole 122 part of housing component 208) is a part of the hearing device (Figs. 1, 10: cavity enclosure structure 120 (composed of housing component 208 in Figs. 9,10) part of hearing aid 100/900/1000). Referring to claim 33, Lin teaches a second air escape hole, wherein the first air escape hole and the second air escape hole are closer to one or respective ones of the two opposite ends of the shield component than to the center of the shielding component (Fig. 9: leftmost hole 133 and uppermost hole 133 closer to respective end corners than to the direct center point of support 13A; para 0065: “The holes 133…as means of …ventilation”). Motivation to combine is the same as in claim 5. Referring to claim 34, Lin teaches a third air escape hole (Fig. 9: lowermost hole 133; para 0065: “The holes 133…as means of …ventilation”). Motivation to combine is the same as in claim 5. Referring to claim 35, Lin teaches the first air escape hole, the second air escape hole, and the third air escape hole are associated with respective corners of the shielding component (Fig. 9: holes 133 at corners of support 13A). Motivation to combine is the same as in claim 5. Referring to claim 36, Lin teaches a second air escape hole, wherein the first air escape hole and the second air escape hole are closer to one or respective ones of the two opposite ends of the shield component than to the center of the shielding component (Fig. 9: leftmost hole 133 and uppermost hole 133 closer to respective corner ends than to the direct center point of support 13A; para 0065: “The holes 133…as means of …ventilation”). Motivation to combine is the same as in claim 14. Referring to claim 37, Lin teaches a third air escape hole (Fig. 9: lowermost hole 133; para 0065: “The holes 133…as means of …ventilation”). Motivation to combine is the same as in claim 14. Referring to claim 38, Lin teaches the first air escape hole, the second air escape hole, and the third air escape hole are associated with respective corners of the shielding component (Fig. 9: holes 133 at corners of support 13A). Motivation to combine is the same as in claim 14. Claim(s) 6 and 11 is/are rejected under 35 U.S.C. 103 as being unpatentable over Pedersen and Lin, as shown in claim 5, in view of Zhu et al. US Publication No. 20070121979. Referring to claim 6, Pedersen teaches the shielding component is made from an electrically conductive material (para 0028). However, Pedersen and Lin do not teach the shielding component being an electromagnetic shield component, but Zhu et al. teaches the shielding component is an electromagnetically shielding component configured to electromagnetically shield at least the first electronic component (para 0013). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to use an electromagnetic shield, as taught in Zhu et al., in the device of Pedersen and Lin because it helps to “reduce the RF coupling from the wireless communications device to those circuits in the hearing aid, causing an audible unwanted noise, such as GSM buzz.” Referring to claim 11, Pedersen and Lin do not teach the electronic component being a power management circuit or the shielding component being an electromagnetic shield component, but Zhu et al. teaches the first electronic component is at least a part of a power management circuit of the hearing device, and wherein the shielding component is configured to reduce electromagnetic interference of the first electronic component (para 0013). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to use an electromagnetic shield on a power circuit, as taught in Zhu et al., in the device of Pedersen and Lin because it helps to “reduce the RF coupling from the wireless communications device to those circuits in the hearing aid, causing an audible unwanted noise, such as GSM buzz.” Response to Arguments Applicant's arguments filed 10/27/25 have been fully considered but they are not persuasive. Applicant states in para 3 on page 9 of the remarks: “As shown above, while Applicant agrees with the Examiner that the hole 133 (on right side) is closer the center of the component 13A than to the top-left end of the component 13A, the hole 133 is not closer to the center to the component 13A to two opposite ends of the component 13A. Thus, Lin fails to make up the deficiencies of Pedersen.” Examiner respectfully disagrees. The two opposite ends are not defined in the claims therefore, the two ends may be any end portions that are opposite to one another. Lin shows the corner by leftmost hole 133 and the corner by uppermost hole 133 are on opposite ends of 13A in Fig. 9. Therefore, Lin teaches the rightmost hole 133 is closer to the center than to the end corners at leftmost and uppermost holes 133. Conclusion Examiner respectfully requests, in response to this Office Action, support be shown for language added to any original claims on amendment and any new claims. That is, indicate support for newly added claim language by specifically pointing to page(s) and line number(s) in the specification and/or drawing figure(s). This will assist Examiner in prosecuting the application. When responding to this Office Action, Applicant is advised to clearly point out the patentable novelty which he or she thinks the claims present, in view of the state of the art disclosed by the references cited or the objections made. He or she must also show how the amendments avoid such references or objections. See 37 CFR 1.111(c). Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATHERINE A FALEY whose telephone number is (571)272-3453. The examiner can normally be reached on Monday to Wednesday, 9am-5pm. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ahmad Matar can be reached on (571) 272-7488. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Any response to this action should be mailed to: Commissioner of Patents and Trademarks P.O. Box 1450 Alexandria, Va. 22313-1450 Or faxed to: (571) 273-8300, for formal communications intended for entry and for informal or draft communications, please label “PROPOSED” or “DRAFT”. Hand-delivered responses should be brought to: Customer Service Window Randolph Building 401 Dulany Street Arlington, VA 22314 Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KATHERINE A FALEY/Primary Examiner, Art Unit 2693
Read full office action

Prosecution Timeline

Apr 22, 2022
Application Filed
Sep 11, 2023
Non-Final Rejection — §103
Oct 20, 2023
Response Filed
Nov 30, 2023
Final Rejection — §103
Jan 08, 2024
Response after Non-Final Action
Jan 16, 2024
Response after Non-Final Action
Jan 24, 2024
Request for Continued Examination
Jan 31, 2024
Response after Non-Final Action
Mar 11, 2024
Non-Final Rejection — §103
Mar 18, 2024
Response Filed
May 06, 2024
Final Rejection — §103
May 28, 2024
Response after Non-Final Action
Jun 24, 2024
Response after Non-Final Action
Jun 27, 2024
Request for Continued Examination
Jul 02, 2024
Response after Non-Final Action
Aug 12, 2024
Non-Final Rejection — §103
Nov 18, 2024
Response Filed
Jan 27, 2025
Final Rejection — §103
Mar 31, 2025
Request for Continued Examination
Apr 01, 2025
Response after Non-Final Action
May 05, 2025
Non-Final Rejection — §103
Jul 21, 2025
Response Filed
Aug 25, 2025
Final Rejection — §103
Oct 27, 2025
Response after Non-Final Action
Nov 05, 2025
Request for Continued Examination
Nov 17, 2025
Response after Non-Final Action
Jan 12, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12604132
HEADSET HAVING VARIABLE BAND STRUCTURE
2y 5m to grant Granted Apr 14, 2026
Patent 12604128
OPEN EARPHONES WITH TWO PRESSURE RELIEF HOLES
2y 5m to grant Granted Apr 14, 2026
Patent 12574669
Earpiece for audiograms
2y 5m to grant Granted Mar 10, 2026
Patent 12574672
CHARGING COIL FOR A HEARING AID CHARGER, HEARING AID CHARGER AND WIRELESS CHARGING SYSTEM
2y 5m to grant Granted Mar 10, 2026
Patent 12556871
BONE CONDUCTION SOUND TRANSMISSION DEVICES
2y 5m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

9-10
Expected OA Rounds
66%
Grant Probability
99%
With Interview (+44.6%)
2y 6m
Median Time to Grant
High
PTA Risk
Based on 439 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month